The goal of this observational study is to assess the effect of intraocular lens (IOL) movement in patients who have undergone Clareon® Vivity® IOL implantation. The main question it aims to answer is: Does an association exist between IOL movement and patient quality of vision? Participants implanted with Clareon® Vivity® and Vivity® Toric IOLs will be asked to do the following: * consent to participate in the study * allow researchers to access their personal medical records * undergo a series of tests to assess the position of their IOLs and quality of vision Researchers will assess participant examination results to determine whether an association exists between IOL movement and patient quality of vision.
This is a non-interventional, single-center, multi-surgeon, observational study to evaluate the effect of intraocular lens (IOL) centration and tilt on visual performance in patients who have undergone Clareon® Vivity® IOL implantation. The study population will include individuals implanted with Clareon® Vivity® and Vivity® Toric IOLs. IOL implantations reviewed will range from the earliest performed (May 2022) onward, until 100 implanted patients (200 eyes) are enrolled. Potential subjects will be consented, then retrospective chart review of pre-operative and operative implantation data will occur and postoperative data will be collected (1 or more months post-operation) via examination.
Study Type
OBSERVATIONAL
Enrollment
101
No intervention
East Coast Institute for Research
Jacksonville, Florida, United States
CDVA100
The mean between Monocular best-corrected distance visual acuity (CDVA100) (logMAR) (High Contrast - 100%).
Time frame: 1 Day
IOL Decentration
The mean value and standard deviation of IOL decentration.
Time frame: 1 day
IOL Tilt
The mean value and standard deviation of IOL tilt.
Time frame: 1 day
UCDVA100
The mean between Uncorrected Distance Visual Acuity (UCDVA100) (logMAR) (High Contrast - 100%)
Time frame: 1 day
UCIVA100
The mean between Uncorrected Intermediate Visual Acuity (UCIVA100) (logMAR) (High Contrast - 100%).
Time frame: 1 day
DCIVA100
The mean between Distance Corrected Intermediate Visual Acuity (100%) (DCIVA100) (logMAR) (High Contrast - 100%).
Time frame: 1 day
MRSE
The mean between Manifest Refraction Spherical Equivalent (MRSE) (D).
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.